HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SPF, critical wavelength tests in lieu of minimum active reg for combos urged -- P&G.

This article was originally published in The Rose Sheet

Executive Summary

SPF, CRITICAL WAVELENGTH TEST USE TO SHOW "SIGNIFICANT CONTRIBUTION" of individual active ingredients in products containing a combination of actives urged by Procter & Gamble in a citizen petition submitted to FDA May 26. The tests would be used in lieu of the OTC sunscreen tentative final monograph requirement that products be formulated using active ingredients at a minimum concentration level. Using the SPF and/or critical wavelength method to demonstrate that each ingredient contributes to increased product efficacy would allow FDA to abolish the minimum concentration level requirements, P&G maintains.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005495

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel